Product Description: Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. [1][2]
Applications: COVID-19-immunoregulation
Formula: C16H26ClNO3
References: [1]Ryuji Sakakibara et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. 2000, March, 15, Pages 191-195./[2]Marquer C et al. Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use inimpotence. Fundam Clin Pharmacol, 1998, 12(4):377-87.
CAS Number: 964-52-3
Molecular Weight: 315.84
Compound Purity: 99.96
Research Area: Cardiovascular Disease; Endocrinology
Solubility: DMSO : 20 mg/mL (ultrasonic)/H2O : ≥ 50 mg/mL
Target: Adrenergic Receptor
English
Deutsch
